Variables | Before treatment | 12 weeks after treatment | Test of significance | P-value | |
---|---|---|---|---|---|
Hemoglobin (g/dL) | Mean ± SD | 13.39 ± 1.49 | 13.28 ± 1.50 | t= 1.713 | 0.095 |
Range | 10.80–16.40 | 10.70–16.40 | |||
TLC (×103/mL) | Mean ± SD | 5.46 ± 1.46 | 5.52 ± 1.51 | t=3.028* | 0.004* |
Range | 2.50–8.80 | 2.50–9.0 | |||
Platelets (×103/mL) | Mean ± SD | 254.9 ± 91.45 | 252.1 ± 87.51 | t= 1.657 | 0.106 |
Range | 84.0–426.0 | 103.0–420.0 | |||
AST (IU/L) | Mean ± SD | 37.25 ± 13.95 | 33.10 ± 13.74 | Z= 5.102* | <0.001* |
Range | 22.0–70.0 | 20.0–65.0 | |||
ALT (IU/L) | Mean ± SD | 38.33 ± 10.52 | 34.30 ± 9.99 | t= 5.801* | <0.001* |
Range | 25.0–65.0 | 20.0–58.0 | |||
Albumin (g/dL) | Mean ± SD | 3.88 ± 0.35 | 4.05 ± 0.33 | t= 9.837* | <0.001* |
Range | 3.0–4.60 | 3.30–4.70 | |||
Total bilirubin (mg/dL) | Mean ± SD | 0.85 ± 0.44 | 0.73 ± 0.32 | Z= 5.520* | <0.001* |
Range | 0.30–2.0 | 0.28–1.80 | |||
INR | Mean ± SD | 1.12 ± 0.18 | 0.97 ± 0.15 | t= 6.376* | <0.001* |
Range | 0.89–1.60 | 0.79–1.50 |